In Silico Study on 5-hydroxy-2-(4-hydroxyphenyl)-6,7- dimethoxychromen-4-one as a Candidate IL-1R and TNF-R Inhibitor. JOMALISC. 2024;3(2):37-44. doi:10.11113/jomalisc.v3.79